About this trial
Peripheral venous catheters (PVCs) are the most commonly used intravascular medical devices in healthcare establishments. Although essential in patient care, PVCs represent a significant risk factor for nosocomial infections, as shown by the results of the national prevalence survey. While the main pathophysiological mechanisms are known, the specific factors driving the transition from simple colonization to infection remain unclear. This project aims to identify the major factors involved in the occurrence of bacterial infections related to the colonization of peripheral venous catheters.
Eligibility criteria
Qualifiers
Patient hospitalized in a care unit of the NOVO hospital (Pontoise site)
Major patient for whom a peripheral venous catheter has been in place for at least 2 days and at most 7 days, with or without signs of inflammation
Disqualifiers
Antibiotic treatment by any route
Patient with viral hepatitis, or human immunodeficiency virus (HIV) or suspected epidemic and biological risk (EBR)
Patient unable to understand and give non-opposition to study participation
Patient under guardianship
Trial design
Treatments tested in this trial
- Inflammatory catheters: catheter removed because of infection at insertion site
- Non-inflammatory catheters: catheter removed because it is no longer relevant to keep it in place
Treatment groups
Sponsors and collaborators
Hôpital NOVO
Lead sponsor
Université de Cergy Pontoise
Collaborator